Box score
Imbria Pharmaceuticals, Inc.
Reported $59.2M sold in a new Form D filed April 1, 2025 (Boston, Massachusetts).
- Biggest raise
- $59.2M filed Apr 1, 2025
- League
- Bio & Health Biotechnology
- Based in
- Boston, Massachusetts
- Season rank
- #59 of 1,311 in the Bio & Health League; #395 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 2
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1745672.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Abcuro, Inc. | Bio & Health | $80M |
| 2 | Dewpoint Therapeutics, Inc. | Bio & Health | $59.1M |
| 3 | Bambusa Therapeutics, Inc. | Bio & Health | $53.3M |
| 4 | Antares Therapeutics, Inc. rookie | Bio & Health | $40M |
| 5 | MarvelBiome, Inc. | Bio & Health | $39.6M |
| 6 | Mediar Therapeutics, Inc. | Bio & Health | $37.8M |